Progressive Multiple Sclerosis Completed Phase 2 Trials for Rituximab (DB00073)

Also known as: Progressive multiple sclerosis

IndicationStatusPhase
DBCOND0051688 (Progressive Multiple Sclerosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01719159Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple SclerosisTreatment